China Health Group Ltd. has announced the completion of a significant corporate reorganization involving a discloseable transaction related to a settlement deed. As of July 18, 2025, the company has fulfilled the conditions of the settlement deed, leading to the transfer of its entire equity interest in Jinmei Developments Limited. This move includes the cancellation of a promissory note valued at HK$146 million and the issuance of a settlement note worth HK$12 million to the noteholder. Consequently, Jinmei Developments Limited and its subsidiaries are no longer part of China Health Group's subsidiaries. The announcement was made by Chung Ho, the Chief Executive Officer and Executive Director of China Health Group, underscoring a strategic shift in the company's operations.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。